Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis. // Current Research in Translational Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2452318626000371?dgcid=rss_sd_all
Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis. Current Research in Translational Medicine. https://www.sciencedirect.com/science/article/pii/S2452318626000371?dgcid=rss_sd_all
“Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis.” Current Research in Translational Medicine.
@article{article3269,
title = {Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis},
journal = {Current Research in Translational Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2452318626000371?dgcid=rss_sd_all}
}